Description
Retatrutide is a triple agonist research peptide studied across GIP, GLP-1, and glucagon receptor pathways. It is commonly compared with Semaglutide and Tirzepatide because it gives researchers a way to study three metabolic receptor systems at the same time instead of one or two.
Molecular Profile
Molecular Weight: ~4,700 Da
Purity: Per batch COA
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
Retatrutide’s triple receptor profile has generated significant interest in metabolic signalling research. Peer-reviewed preclinical literature documents its utility in studying simultaneous activation of GIP, GLP-1, and glucagon receptor pathways, including downstream effects on adipose tissue biology, hepatic glucose output, and energy expenditure regulation. Research teams investigating incretin-based signalling cascades use triple agonist compounds to isolate receptor-specific contributions to metabolic outcomes.
Quality Assurance
Each batch is independently tested for purity, identity, and quality before release. A Certificate of Analysis is available for every lot. All compounds are produced under strict quality control conditions and shipped under appropriate handling protocols from within Canada.
